Article

I'll have pineapple with that

Author(s):

A couple of months ago, I wrote a blog about the importance of drinking water, especially for cancer patients. One of our readers asked a question that I thought was important as it could help people increase their water intake. "Adrienne" asked if adding fresh mint, ginger or honey to purified water makes a difference. This is a question I've wanted to know the answer to so I contacted Milton Stokes, MPH, CDN, who is a registered dietitian and owner of One Source Nutrition, a nutritional consulting and counseling firm. Milton also sits on the board of CURE magazine. Here's what Milton said if you missed it: "As a Registered Dietitian, I always counsel my clients to tweak/alter beverages (and foods) to fit their individual preferences. So if you like mint and ginger in your water--I certainly do!--then go for it. Whatever gets you to your goal. And your add-ins may help digestion, which is another bonus! If you need some sweetness, honey is fine. Just hone in on what "a little" really means. Is it a lengthy squirt from the bear-shaped container? Or are we talking a teaspoon? While honey provides antioxidants, it also delivers calories. So if you're trying to lose weight, you may wish to minimize or skip the honey. Another option: sliced oranges or berries in the water. That's your call. Just glad you're focused on hydration."I've put citrus in my water before, but I hadn't tried berries so I sliced up a few strawberries today in my water, and it was yummy! Thanks, Milton, for the great input. I'm sure other fruits can be just as tasty. I think I'll try pineapple tonight.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content